Business Description
Medicofarma Biotech SA
ISIN : PLINBOK00010
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 30 | |||||
Equity-to-Asset | 0.64 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.31 | |||||
Beneish M-Score | -3.36 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -72.7 | |||||
3-Year EBITDA Growth Rate | 43.8 | |||||
3-Year EPS without NRI Growth Rate | 26.6 | |||||
3-Year FCF Growth Rate | 29.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.42 | |||||
9-Day RSI | 34.02 | |||||
14-Day RSI | 32.32 | |||||
6-1 Month Momentum % | -23.93 | |||||
12-1 Month Momentum % | -20.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.73 | |||||
Quick Ratio | 0.73 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 91.55 | |||||
Days Payable | 1588.75 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -115.6 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.5 | |||||
Operating Margin % | -145.29 | |||||
Net Margin % | -227.39 | |||||
FCF Margin % | 23.42 | |||||
ROE % | -28.84 | |||||
ROA % | -19.81 | |||||
ROIC % | -12.15 | |||||
ROC (Joel Greenblatt) % | -24.1 | |||||
ROCE % | -25.76 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 22.86 | |||||
PB Ratio | 3.29 | |||||
Price-to-Tangible-Book | 3.69 | |||||
Price-to-Free-Cash-Flow | 96 | |||||
Price-to-Operating-Cash-Flow | 28.24 | |||||
EV-to-EBIT | -11.19 | |||||
EV-to-EBITDA | -32.63 | |||||
EV-to-Revenue | 24.03 | |||||
EV-to-FCF | 102.6 | |||||
Price-to-Median-PS-Value | 24 | |||||
Earnings Yield (Greenblatt) % | -8.94 | |||||
FCF Yield % | 0.97 |